← Back to Search

Simultaneous UroLift™ and HoLEP for Enlarged Prostate

N/A
Recruiting
Led By Donald Neff
Research Sponsored by University of Kansas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 months
Awards & highlights

Study Summary

To evaluate postoperative outcomes of BPH/Lower urinary tract symptoms, erectile function, and ejaculatory capacity of simultaneous UroLiftTM and Holmium laser enucleation of the prostatic median lobe.

Eligible Conditions
  • Enlarged Prostate

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
International Prostate Symptom Score (IPSS) change (improvement) from baseline at 3 and 12 months.
Secondary outcome measures
Post-Operative measurement of Peak Urine Flow Rate (Qmax)
Post-Operative measurement of Post Void Residual (PVR)
Post-operative participant reported outcomes using International Index of Erectile Function (IIEF).
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Simultaneous UroLift™ and HoLEPExperimental Treatment1 Intervention
UroLift System

Find a Location

Who is running the clinical trial?

University of Kansas Medical CenterLead Sponsor
463 Previous Clinical Trials
169,260 Total Patients Enrolled
Donald NeffPrincipal InvestigatorUniversity of Kansas Medical Center
1 Previous Clinical Trials
10 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
IIT-2022-Simultaneous Urolift™ and Median Lobe Enucleation
Don Neff, MD, FACS 2023. "IIT-2022-Simultaneous Urolift™ and Median Lobe Enucleation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06157164.
All > Kansas City
~4 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top